EquityZen Growth Technology Fund LLC - Series 361
Raised
$307K
Investors
17
Min Invest
$10,105
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 361 is a Delaware pooled investment fund filed by EquityZen Advisors LLC on 2019-02-26, raising $307K from 17 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This is part of EquityZen's pre-IPO secondary market platform, which operates 1,891 related series-based SPVs providing accredited investors access to private company shares.
This pre-IPO vehicle employs the standard 506(b)/3(c)(1) exemption pairing typical of EquityZen's series-based SPV model, with a $10K minimum characteristic of retail-accessible accredited investor structures. The $18K average check size across 17 investors reflects the platform's deal-by-deal syndication approach to fractionalizing secondary stakes in private growth companies.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.